Cosmo Pharmaceuticals N.V. (FRA:C43)

Germany flag Germany · Delayed Price · Currency is EUR
98.50
+5.00 (5.35%)
At close: Dec 5, 2025
48.12%
Market Cap 1.56B
Revenue (ttm) 182.27M
Net Income (ttm) 59.99M
Shares Out n/a
EPS (ttm) 3.67
PE Ratio 25.92
Forward PE 333.50
Dividend 2.05 (2.95%)
Ex-Dividend Date Jun 4, 2025
Volume 690
Average Volume 131
Open 96.00
Previous Close 93.50
Day's Range 95.50 - 98.50
52-Week Range 47.80 - 98.50
Beta n/a
RSI 78.80
Earnings Date Mar 6, 2026

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 322
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C43
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.